Forty-Eight Week Study of Study Drug in Patients with Alzheimer's
Twenty-Four Week Study of Study Drug in Patient with Dementia
Associated with Vascular Disease.
Multicenter, Open Label Trial Evaluating the Safety and Tolerability
of Study Drug in the Treatment of Elderly Subjects with Selected
Idiopathic and Organic Psychosis.
Randomized, Triple-Blind, Double Dummy, Placebo-Controlled,
Parallel Groups, Outpatient Study to Examine the Safety and
Efficacy of Study Drug for the Treatment of Acute Migraine
and Migraine Recurrence.
Drug vs. Placebo in OCD Relapse Prevention.
| 1993 | 1994
| 1995 | 1996
| 1997 | 1998
| 2001 |
2003 | 2004 | 2005 | 2006
home | about us | principal
investigator | clinical trials
| interest form | directions